Abcellera Stock Analysis

ABCL -  USA Stock  

USD 15.69  0.84  5.66%

The big decline in price over the last few months for Abcellera Biologics could raise concerns from stakeholders as the firm it trading at a share price of 15.69 on 1,152,489 in volume. The company management teams failed to add value to investors and positioning the firm supply of money to exploit market volatility in June. However, diversifying your holdings with Abcellera Biologics or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.27. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Abcellera Biologics partners.
Please continue to Trending Equities.

Search Stock Analysis 

The Abcellera Biologics stock analysis report makes it easy to digest most publicly released information about Abcellera Biologics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Abcellera Stock analysis module also helps to analyze the Abcellera Biologics price relationship with some important fundamental indicators such as market cap and management efficiency.

Abcellera Stock Analysis Notes

The company had not issued any dividends in recent years. AbCellera Biologics Inc. develops antibody discovery platform. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada. Abcellera Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 174 people. For more info on Abcellera Biologics please contact the company at 604 559 9005 or go to

Abcellera Biologics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Abcellera Biologics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Abcellera Biologics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Abcellera Biologics generates negative expected return over the last 90 days
Abcellera Biologics has high historical volatility and very poor performance
Abcellera Biologics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 28.45 M. Net Loss for the year was (283.6 K) with profit before overhead, payroll, taxes, and interest of 1.5 M.
Latest headline from Year-To-Date, AbCellera Biologics Inc. Price Has Decrease -60.16. Does Trouble Ahead - Marketing Sentinel

Abcellera Biologics Thematic Classifications

In addition to having Abcellera Biologics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Biotech IdeaBiotech
Biotechnology and pharmaceuticals production and services

Abcellera Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 12.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abcellera Biologics's market, we take the total number of its shares issued and multiply it by Abcellera Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Abcellera Profitablity

Abcellera Biologics' profitability indicators refer to fundamental financial ratios that showcase Abcellera Biologics' ability to generate income relative to its revenue or operating costs. If, let's say, Abcellera Biologics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Abcellera Biologics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Abcellera Biologics' profitability requires more research than a typical breakdown of Abcellera Biologics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.98 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (23.62) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.24.

Management Efficiency

Abcellera Biologics management efficiency ratios could be used to measure how well abcellera biologics manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 28th of July, Abcellera Biologics shows the risk adjusted performance of (0.21), and Mean Deviation of 2.58. Abcellera Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Abcellera Biologics, which can be compared to its rivals. Please confirm Abcellera Biologics jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Abcellera Biologics is priced correctly, providing market reflects its regular price of 15.69 per share. Given that Abcellera Biologics has jensen alpha of (1.05), we suggest you to validate Abcellera Biologics's prevailing market performance to make sure the company can sustain itself at a future point.

Abcellera Biologics Price Movement Analysis

The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Abcellera Biologics price series. View also all equity analysis or get more info about hilbert transform instantaneous trendline overlap studies indicator.

Abcellera Biologics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abcellera Biologics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abcellera Biologics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abcellera Biologics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Abcellera Biologics Predictive Daily Indicators

Abcellera Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abcellera Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Abcellera Biologics Forecast Models

Abcellera Biologics time-series forecasting models is one of many Abcellera Biologics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abcellera Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Abcellera Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Abcellera Biologics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abcellera shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Abcellera Biologics. By using and applying Abcellera Stock analysis, traders can create a robust methodology for identifying Abcellera entry and exit points for their positions.
AbCellera Biologics Inc. develops antibody discovery platform. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada. Abcellera Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 174 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Abcellera Biologics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Instant Ratings Now


Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Please continue to Trending Equities. Note that the Abcellera Biologics information on this page should be used as a complementary analysis to other Abcellera Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Abcellera Stock analysis

When running Abcellera Biologics price analysis, check to measure Abcellera Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera Biologics is operating at the current time. Most of Abcellera Biologics' value examination focuses on studying past and present price action to predict the probability of Abcellera Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abcellera Biologics' price. Additionally, you may evaluate how the addition of Abcellera Biologics to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Directory
Find actively traded corporate debentures issued by US companies
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Abcellera Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.